These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1415187)

  • 21. Tissue factor-like activity of the human monocytic tumor cell line U937.
    Hudig D; Bajaj SP
    Thromb Res; 1982 Aug; 27(3):321-32. PubMed ID: 6753233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes.
    Herbert JM; Savi P; Laplace MC; Lalé A; Dol F; Dumas A; Labit C; Minty A
    FEBS Lett; 1993 Aug; 328(3):268-70. PubMed ID: 8102337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of inhibition of immunoglobulin G-mediated phagocytosis by monoclonal antibodies that recognize the Mac-1 antigen.
    Brown EJ; Bohnsack JF; Gresham HD
    J Clin Invest; 1988 Feb; 81(2):365-75. PubMed ID: 2963020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinctive features of procoagulant response of monocytes from diabetic patients.
    Jude B; Watel A; Fontaine O; Fontaine P; Cosson A
    Haemostasis; 1989; 19(2):65-73. PubMed ID: 2731777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endotoxin priming of monocytes augments Fc gamma receptor cross-linking-induced TNF-alpha and IL-1 beta release.
    Kindt GC; Moore SA; She ZW; Wewers MD
    Am J Physiol; 1993 Aug; 265(2 Pt 1):L178-85. PubMed ID: 8396339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lupus antibody bivalency is required to enhance prothrombin binding to phospholipid.
    Field SL; Chesterman CN; Dai YP; Hogg PJ
    J Immunol; 2001 May; 166(10):6118-25. PubMed ID: 11342631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
    Hattori T; Khan MM; Colman RW; Edmunds LH
    J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The endotoxin-induced coagulant activity of human monocytes.
    Rivers RP; Hathaway WE; Weston WL
    Br J Haematol; 1975 Jul; 30(3):311-6. PubMed ID: 1201214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD40 engagement induces monocyte procoagulant activity through an interleukin-10 resistant pathway.
    Pradier O; Willems F; Abramowicz D; Schandené L; de Boer M; Thielemans K; Capel P; Goldman M
    Eur J Immunol; 1996 Dec; 26(12):3048-54. PubMed ID: 8977303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of monocyte function in breast disease.
    Spillert CR; Curtis GT; Lazaro EJ
    South Med J; 1988 Feb; 81(2):164-6. PubMed ID: 3277286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibition by pentoxifylline of procoagulant activity produced by endotoxin-active monocytes].
    de Prost D; Ollivier V; Hakim J
    C R Seances Soc Biol Fil; 1992; 186(3):186-92. PubMed ID: 1283564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of the monocyte to thrombotic potential.
    Spillert CR; Lazaro EJ
    Agents Actions; 1991 Sep; 34(1-2):28-9. PubMed ID: 1793044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IV. Anticoagulant activity of compound 48/80: inhibition of factor VII activation in leukemia THP-1 monocytes.
    Chu AJ; Wang ZG; Raphael UO
    J Cardiovasc Pharmacol; 2000 Nov; 36(5):649-55. PubMed ID: 11065226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for an essential role of tissue factor dependent blood coagulation in the pathogenesis of the local Shwartzman reaction.
    Zivelin A; Rao LV; Rapaport SI
    Blood Cells Mol Dis; 1995; 21(1):9-19. PubMed ID: 7655863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocyte procoagulant activity induced by adherence to an artificial surface is reduced by end-point immobilized heparin-coating of the surface.
    Barstad RM; Hamers MJ; Møller AS; Sakariassen KS
    Thromb Haemost; 1998 Feb; 79(2):302-5. PubMed ID: 9493580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor measurement and use of different anticoagulants: possible interference in plasma samples and supernatants from endotoxin-stimulated monocytes.
    Hoffmann JN; Hartl WH; Faist E; Jochum M; Inthorn D
    Inflamm Res; 1997 Sep; 46(9):342-7. PubMed ID: 9339389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
    Lale A; Herbert JM; Augereau JM; Billon M; Leconte M; Gleye J
    J Nat Prod; 1996 Mar; 59(3):273-6. PubMed ID: 8882428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue factor expression in endothelial cell/monocyte cocultures stimulated by lipopolysaccharide and/or aggregated IgG. Mechanisms of cell:cell communication.
    Wharram BL; Fitting K; Kunkel SL; Remick DG; Merritt SE; Wiggins RC
    J Immunol; 1991 Mar; 146(5):1437-45. PubMed ID: 1993838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor primes endotoxin-stimulated macrophage procoagulant activity.
    Kucey DS; Kubicki EI; Rotstein OD
    J Surg Res; 1991 May; 50(5):436-41. PubMed ID: 2038182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.